Heart scans reveal hidden dangers of untreated preeclampsia
NCT ID NCT06099275
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study aims to measure how well the heart pumps blood in people with untreated preeclampsia compared to healthy pregnant women. Researchers will use a non-invasive ultrasound (echocardiography) to check heart function at rest, after blood pressure medication, and during delivery and recovery. The study plans to enroll 80 participants but is currently suspended.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand how preeclampsia affects the heart, potentially leading to improved monitoring or treatment approaches.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly change patient care. The study is currently suspended, and results may not apply to all patients with preeclampsia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
80 pregnant people will be recruited; 40 with preeclampsia, and 40 healthy normotensive pregnant people.
- Ages
-
18 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Preeclampsia Participant. 1. Preclampsia definition: People with preeclampsia will be recruited at the time of diagnosis or suspected diagnosis of preeclampsia, according to accepted definitions of preeclampsia. Preeclampsia with severe features will be defined using the American College of Obstetrics and Gynecology definition. 2. Nulliparous, singleton pregnancy, 3. ≥20 weeks gestation 4. without any preexisting cardiovascular, hepatic, or respiratory problems, 5. No preexisting uterine abnormality including benign tumors, or placental adhesive disorder, 6. Not in labor, 7. Not with prior to treatment for preeclampsia, 8. Body mass index ≤ 40 kg/m2, age 18 to 50 years. Healthy Participant: Healthy pregnant people will be defined as 1. American Society of Anesthesiologists (ASA) Classification II with no significant medical or surgical illness, 2. Nulliparous (first pregnancy beyond 20 week's gestation) 3. Non-smokers, singleton pregnancy 4. Not having ruptured membranes 5. No uterine abnormalities 6. No placentation abnormalities. 7. Not receiving any vasoactive medication including salbutamol 8. Not on thyroid replacement hormones Exclusion Criteria: Preeclampsia Participant: 1. Multiparous, multiple pregnancy, 2. Previous cardiovascular, hepatic or respiratory problems 3. Gestational diabetes, 4. Hemodynamic or neurologically unstable patient 5. Unable to tolerate a 30-minute ultrasound examination (TTE) 6. Age less than 18 or greater than 50 years 7. BMI \> 40 kg/m2, 8. Gestation \< 20 weeks. Healthy Participant: 1. Current administration of vasoactive drugs including salbutamol 2. Current administration of thyroxine 3. Pre-existing or gestational diabetes 4. Tobacco use 5. Pre-existing or gestational hypertension or preeclampsia 6. Known uterine abnormality, in labor or ruptured membranes 7. Unable to tolerate a 30-minute ultrasound examination (TTE) 8. Age less than 18 or greater than 50 years 9. BMI \> 40 kg/m2, 10. Gestation \< 20 weeks.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Preeclampsia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a fetal heart ultrasound index predict trouble in High-Risk pregnancies?
- A bracelet and a blood pressure cuff: a simple plan to protect new mothers at risk
- Can a Light-Based scan spot preeclampsia before it strikes?
- Can a malaria drug help prevent preeclampsia?
- Which drug best steadies blood pressure during C-Section in preeclampsia?
- Two common drugs face off to shield mothers from a dangerous drop in blood pressure